Contact
Please use this form to send email to PR contact of this press release:
Nexien BioPharma Advance in Clinical Use of Cannabinoid Based-Formulation for Treating Myotonic Dystrophies and Myotonia
TO:
Drew White
NisonCo PR
+1 631-520-1435